Request Trial
shutterstock_1940448004_hjbc
HJBC / Shutterstock.com
21 February 2023PharmaLiz Hockley

Sanofi backed by big pharma and more in SCOTUS clash

Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca | Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
21 August 2026   Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis.
Pharma
SK Biopharmaceuticals settles epilepsy generic dispute
20 August 2026   A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products.
Pharma
Vanda revives challenge over braille-free label on generic sleep disorder drug
19 August 2026   Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach.


Editor's picks

Abbott fends off Chinese rival’s patent challenge at UPC
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026

Editor's picks

MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026

More features

Teva and Aurinia settle generics dispute over lupus drug, voclosporin
10x Genomics dealt major blow in sequencing fight
SK Biopharmaceuticals settles epilepsy generic dispute
Vanda revives challenge over braille-free label on generic sleep disorder drug
Abbott fends off Chinese rival’s patent challenge at UPC
Former head of litigation at Nokia returns to Bird & Bird
Former USPTO acting director takes the helm at C4IP
Europe’s missing biotech bridge: Why IP ownership matters more than capital access